Thomas Ebeling

Insider Reports History

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Ebeling:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Director Common Stock 187K $2.43M $13.00 Jun 10, 2024 Direct
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 0 Jun 10, 2024 Direct

Insider Reports Filed by Thomas Ebeling

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Therapeutics, Inc. Jun 10, 2024 2 $240K 4 Jun 11, 2024 Director
CGEM Cullinan Therapeutics, Inc. May 23, 2024 4 $572K 4 May 23, 2024 Director
CGEM Cullinan Oncology, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
CGEM Cullinan Oncology, Inc. Jun 22, 2022 1 $0 4 Jun 23, 2022 Director
CGEM Cullinan Oncology, Inc. Sep 16, 2021 1 $0 4 Mar 25, 2022 Director